Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery.
Ghanem MS, Caffa I, Del Rio A, Franco J, Parenti MD, Monacelli F, Cea M, Khalifa A, Nahimana A, Duchosal MA, Ravera S, Bertola N, Bruzzone S, Nencioni A, Piacente F.
Ghanem MS, et al. Among authors: ravera s.
Pharmaceuticals (Basel). 2022 Jul 10;15(7):848. doi: 10.3390/ph15070848.
Pharmaceuticals (Basel). 2022.
PMID: 35890147
Free PMC article.